N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 2.168 NOK 1.59% Market Closed
Market Cap: 708m NOK
Have any thoughts about
Nykode Therapeutics ASA?
Write Note

Nykode Therapeutics ASA
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nykode Therapeutics ASA
Note Receivable Peer Comparison

Comparables:
HBC
B
BGBIO
L
LYTIX
AZT
T
TRMED

Competitive Note Receivable Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
N
Nykode Therapeutics ASA
OSE:NYKD
Note Receivable
$30.5m
CAGR 3-Years
286%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bergenbio ASA
OSE:BGBIO
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Nykode Therapeutics ASA's Note Receivable?
Note Receivable
30.5m USD

Based on the financial report for Jun 30, 2024, Nykode Therapeutics ASA's Note Receivable amounts to 30.5m USD.

What is Nykode Therapeutics ASA's Note Receivable growth rate?
Note Receivable CAGR 3Y
286%

Over the last year, the Note Receivable growth was 64 796%. The average annual Note Receivable growth rates for Nykode Therapeutics ASA have been 286% over the past three years .

Back to Top